- Home
- CPRI vs ARWR Comparison
CPRI vs ARWR Comparison
Compare CPRI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRI
- ARWR
- Stock Information
- Founded
- CPRI 1981
- ARWR 2003
- Country
- CPRI United Kingdom
- ARWR United States
- Employees
- CPRI N/A
- ARWR N/A
- Industry
- CPRI Apparel
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- CPRI Consumer Discretionary
- ARWR Health Care
- Exchange
- CPRI Nasdaq
- ARWR Nasdaq
- Market Cap
- CPRI 2.5B
- ARWR 1.7B
- IPO Year
- CPRI 2011
- ARWR 1993
- Fundamental
- Price
- CPRI $19.74
- ARWR $12.74
- Analyst Decision
- CPRI Buy
- ARWR Buy
- Analyst Count
- CPRI 11
- ARWR 11
- Target Price
- CPRI $26.18
- ARWR $41.44
- AVG Volume (30 Days)
- CPRI 3.6M
- ARWR 1.6M
- Earning Date
- CPRI 02-05-2025
- ARWR 05-08-2025
- Dividend Yield
- CPRI N/A
- ARWR N/A
- EPS Growth
- CPRI N/A
- ARWR N/A
- EPS
- CPRI N/A
- ARWR N/A
- Revenue
- CPRI $4,630,000,000.00
- ARWR $2,500,000.00
- Revenue This Year
- CPRI N/A
- ARWR $4,380.43
- Revenue Next Year
- CPRI N/A
- ARWR $58.72
- P/E Ratio
- CPRI N/A
- ARWR N/A
- Revenue Growth
- CPRI N/A
- ARWR N/A
- 52 Week Low
- CPRI $18.52
- ARWR $12.20
- 52 Week High
- CPRI $45.77
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- CPRI 40.37
- ARWR 27.27
- Support Level
- CPRI $20.02
- ARWR $14.69
- Resistance Level
- CPRI $21.61
- ARWR $15.65
- Average True Range (ATR)
- CPRI 0.87
- ARWR 0.78
- MACD
- CPRI -0.01
- ARWR -0.12
- Stochastic Oscillator
- CPRI 28.96
- ARWR 13.07
Stock Price Comparison Chart: CPRI vs ARWR
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. John Idol has served as CEO since 2003.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.